Boostrix Warnings and Precautions
There are several precautions and warnings with Boostrix to be aware of before receiving this vaccine. For example, you may not be able to take it if you have epilepsy, diabetes, or cancer. Also, make sure your healthcare provider knows if you have ever had any serious reactions to vaccines in the past. Safety concerns also apply to women who are pregnant or breastfeeding.
You should talk with your healthcare provider prior to receiving Boostrix® (Tdap vaccine) if you have:
- Guillain-Barré syndrome
- A recent history of stroke
- An immune-suppressing condition, such as HIV/AIDS, diabetes, or cancer
- Had any sort of a reaction to any vaccine in the past
- Epilepsy or any other nervous system disorder
- A moderate to severe illness
- Any allergies, including allergies to foods, dyes, or preservatives.
Also, let your healthcare provider know if you are:
- Pregnant or thinking of becoming pregnant
Make sure to tell your healthcare provider about any medications you are taking, including prescription and nonprescription medicines, vitamins, and herbal supplements.
Some warnings and precautions to be aware of prior to taking Boostrix include the following:
- Make sure your healthcare provider knows if you have ever had any serious reactions to any vaccines in the past. It is a good idea to ask your parents or other caregivers if you had any problems with your childhood vaccinations.
- There is some evidence that tetanus toxoid (one of the components of Boostrix) might be linked to Guillain-Barré syndrome (a serious nervous system problem).
- Make sure your healthcare provider knows if you have (or have had) epilepsy, seizures, a stroke, or any other nervous system disorders. In some cases, Boostrix may need to be postponed; in other cases, the vaccine may not be recommended at all.
- If you have had severe swelling or pain with any previous vaccine that contained tetanus toxoid, you should not receive Boostrix unless at least 10 years have passed since your last vaccination with tetanus toxoid.
- Boostrix does not contain thimerosal (a mercury-containing preservative). Individuals who are concerned about exposure to thimerosal can be confident that this vaccine has no thimerosal (not even trace amounts). Some people are concerned about aluminum content of vaccines; Boostrix contains no more than 0.39 mg of aluminum per dose.
- This vaccine is not made from human fetal components, as some vaccines are. It is, however, made from bovine (cow) components.
- Make sure to tell your healthcare provider if you are allergic to latex. The prefilled Boostrix syringes may contain latex. The vial form of Boostrix does not contain latex.
- If you have an immune-suppressing condition, Boostrix may not be as effective as usual for producing immunity to diphtheria, tetanus, or pertussis.
- This vaccine can potentially interact with a few other medications or vaccines (see Boostrix Drug Interactions).
- Boostrix is considered a pregnancy Category B medication, which means that it is probably safe for use during pregnancy (see Boostrix and Pregnancy).
- At this time, it is unknown if Boostrix passes through breast milk. If you are breastfeeding, make sure to check with your healthcare provider before receiving this vaccine (see Boostrix and Breastfeeding).